Cancer Research and Treatment

The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study

Dinh-Toi Chu, Mai Vu Ngoc Suong, Hue Vu Thi, Thuy-Duong Vu, Manh-Hung Nguyen, Vijai Singh

Expert Review of Molecular Diagnostics.2023; 23(1): 53. CrossRef

Survival outcomes in patients withBRCAmutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors

Lucia Musacchio, Serena Boccia, Claudia Marchetti, Angelo Minucci, Floriana Camarda, Chiara Cassani, Jole Ventriglia, Vanda Salutari, Viola Ghizzoni, Elena Giudice, Maria Teresa Perri, Maria Vittoria Carbone, Caterina Ricci, Sandro Pignata, Anna Fagotti,

International Journal of Gynecologic Cancer.2023; 33(6): 922. CrossRef

Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models

Garrett M. Draper, Daniel J. Panken, David A. Largaespada

Genes, Chromosomes and Cancer.2023; 62(9): 493. CrossRef

Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma

Brooke B. Bartow, Gene P. Siegal, Ceren Yalniz, Ahmed M. Elkhanany, Lei Huo, Qingqing Ding, Aysegul A. Sahin, Hua Guo, Cristina Magi-Galluzzi, Shuko Harada, Xiao Huang

Factors predictingBRCA1/2pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis

Giovanni Innella, Lea Godino, Giulia Erini, Antonio De Leo, Donatella Santini, Anna Myriam Perrone, Pierandrea De Iaco, Claudio Zamagni, Daniela Turchetti

Journal of Clinical Pathology.2023; 76(8): 510. CrossRef

Association of BRCA1/2 mutations with prognosis and surgical cytoreduction outcomes in ovarian cancer patients: An updated meta‐analysis

Journal of Obstetrics and Gynaecology Research.2022; 48(9): 2270. CrossRef

Recurrent Ovarian Cancer with BRCAness Phenotype: A Treatment Challenge

Cláudia Caeiro, Inês Leão, Inês Oliveira, Isabel Sousa, Teresa André

Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients

Giorgia Gurioli, Gianluca Tedaldi, Alberto Farolfi, Elisabetta Petracci, Claudia Casanova, Giuseppe Comerci, Rita Danesi, Valentina Arcangeli, Mila Ravegnani, Daniele Calistri, Valentina Zampiga, Ilaria Cangini, Eugenio Fonzi, Alessandra Virga, Davide Tas

International Journal of Molecular Sciences.2022; 23(24): 15789. CrossRef

Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis

Shira Peleg Hasson, Dov Hershkovitz, Lyri Adar, Miriam Brezis, Eliya Shachar, Rona Aks, Lee Galmor, Yuval Raviv, Shira Ben Neriah, Ofer Merimsky, Edmond Sabo, Ido Wolf, Tamar Safra

Current update on malignant epithelial ovarian tumors

Sherif B. Elsherif, Priya R. Bhosale, Chandana Lall, Christine O. Menias, Malak Itani, Kristina A. Butler, Dhakshinamoorthy Ganeshan

Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer

Kyung Jin Eoh, Hye Min Kim, Jung-Yun Lee, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Eun Ji Nam

Association of Germline Variants in Human DNA Damage Repair Genes and Response to Adjuvant Chemotherapy in Resected Pancreatic Ductal Adenocarcinoma

Haijie Hu, Yayun Zhu, Ning Pu, Richard A. Burkhart, William Burns, Daniel Laheru, Lei Zheng, Jin He, Michael G. Goggins, Jun Yu

Journal of the American College of Surgeons.2020; 231(5): 527. CrossRef

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers

Hyeong In Ha, Jin-Sun Ryu, Hyoeun Shim, Sun-Young Kong, Myong Cheol Lim

Journal of Gynecologic Oncology.2020;[Epub] CrossRef

Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts

Anastasis Oulas, George Minadakis, Margarita Zachariou, George M. Spyrou

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer

Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song

Clinical significance of variants of unknown significances in BRCA genes

Journal of Gynecologic Oncology.2019;[Epub] CrossRef

DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies

Mohammad Mirza-Aghazadeh-Attari, Caspian Ostadian, Amir Ata Saei, Ainaz Mihanfar, Saber Ghazizadeh Darband, Shirin Sadighparvar, Mojtaba Kaviani, Hossein Samadi Kafil, Bahman Yousefi, Maryam Majidinia

Clinical and Genetic Characteristics of BRCA1/2 Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review

Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim

Cancer Research and Treatment.2019; 51(3): 941. CrossRef

Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea

Jun Hyeong Seo, Soo Young Jeong, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi

Obstetrics & Gynecology Science.2019; 62(6): 411. CrossRef

Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer

Min Chul Choi, Ja-Hyun Jang, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Je Ho Lee

International Journal of Gynecological Cancer.2018; 28(2): 308. CrossRef

Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube

Min Chul Choi, Jin-Sik Bae, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Ji-Ho Kim, Ki-Chan Lee, Sunghoon Lee, Je Ho Lee

Journal of Gynecologic Oncology.2018;[Epub] CrossRef

Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2

Kyung Jin Eoh, Ji Eun Kim, Hyung Seok Park, Seung-Tae Lee, Ji Soo Park, Jung Woo Han, Jung-Yun Lee, Sunghoon Kim, Sang Wun Kim, Jae Hoon Kim, Young Tae Kim, Eun Ji Nam

Cancer Research and Treatment.2018; 50(3): 917. CrossRef

International Journal of Gynecologic Cancer.2018; 28(8): 1514. CrossRef

BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic‐related mutations in BRCA1 associated with an increased risk of ovarian cancer

Tingyan Shi, Pan Wang, Caixia Xie, Sheng Yin, Di Shi, Congchong Wei, Wenbin Tang, Rong Jiang, Xi Cheng, Qingyi Wei, Qing Wang, Rongyu Zang

International Journal of Cancer.2017; 140(9): 2051. CrossRef

Role and clinical application of next-generation sequencing (NGS) for ovarian cancer

Journal of Gynecologic Oncology.2017;[Epub] CrossRef